JP2005529102A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005529102A5 JP2005529102A5 JP2003583372A JP2003583372A JP2005529102A5 JP 2005529102 A5 JP2005529102 A5 JP 2005529102A5 JP 2003583372 A JP2003583372 A JP 2003583372A JP 2003583372 A JP2003583372 A JP 2003583372A JP 2005529102 A5 JP2005529102 A5 JP 2005529102A5
- Authority
- JP
- Japan
- Prior art keywords
- aerosol
- formulation
- compound
- formulation according
- aerosol pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000443 aerosol Substances 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 6
- 238000009472 formulation Methods 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 claims 1
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 claims 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 229960003728 ciclesonide Drugs 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 229920002313 fluoropolymer Polymers 0.000 claims 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 claims 1
- 229960002848 formoterol Drugs 0.000 claims 1
- -1 isobutanoyl Chemical group 0.000 claims 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 239000003380 propellant Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0207899.6A GB0207899D0 (en) | 2002-04-05 | 2002-04-05 | Formoterol and cielesonide aerosol formulations |
| GB0207899.6 | 2002-04-05 | ||
| PCT/US2003/010285 WO2003086349A1 (en) | 2002-04-05 | 2003-04-01 | Formoterol and ciclesonide aerosol formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005529102A JP2005529102A (ja) | 2005-09-29 |
| JP2005529102A5 true JP2005529102A5 (enExample) | 2006-06-01 |
| JP5198716B2 JP5198716B2 (ja) | 2013-05-15 |
Family
ID=9934322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003583372A Expired - Fee Related JP5198716B2 (ja) | 2002-04-05 | 2003-04-01 | フォルモテロールおよびシクレソニドのエアロゾル製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20050207984A1 (enExample) |
| EP (1) | EP1492500B1 (enExample) |
| JP (1) | JP5198716B2 (enExample) |
| AT (1) | ATE401056T1 (enExample) |
| AU (1) | AU2003262146A1 (enExample) |
| CA (1) | CA2481187A1 (enExample) |
| DE (1) | DE60322200D1 (enExample) |
| GB (1) | GB0207899D0 (enExample) |
| WO (1) | WO2003086349A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003293833B2 (en) * | 2002-12-12 | 2009-10-01 | Covis Pharma B.V. | Combination medicament |
| AU2004241746A1 (en) * | 2003-05-22 | 2004-12-02 | Nycomed Gmbh | Salmeterol and ciclesonide combination |
| GB0312148D0 (en) | 2003-05-28 | 2003-07-02 | Aventis Pharma Ltd | Stabilized pharmaceutical products |
| EP1635845A1 (en) * | 2003-06-13 | 2006-03-22 | ALTANA Pharma AG | Formoterol and ciclesonide combination |
| GB0315889D0 (en) | 2003-07-08 | 2003-08-13 | Aventis Pharma Ltd | Stable pharmaceutical products |
| GB0323684D0 (en) | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
| GB0323685D0 (en) * | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
| US20060045891A1 (en) * | 2004-08-24 | 2006-03-02 | Lovalenti Phillip M | Density-matched suspension vehicles and pharmaceutical suspensions |
| DE102006053374A1 (de) * | 2006-02-09 | 2007-08-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz |
| GB0918149D0 (en) | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved medicinal aerosol formulation |
| US20120272951A1 (en) * | 2009-12-16 | 2012-11-01 | 3M Innovative Properties Company | Formulations and methods for controlling mdi particle size delivery |
| WO2013167429A1 (de) * | 2012-05-09 | 2013-11-14 | Boehringer Ingelheim International Gmbh | Zerstäuber |
| WO2016018892A1 (en) | 2014-07-29 | 2016-02-04 | 3M Innovative Properties Company | Method of preparing a pharmaceutical composition |
| WO2018059390A1 (zh) * | 2016-09-29 | 2018-04-05 | 广东东阳光药业有限公司 | 药物组合物 |
| US11964121B2 (en) | 2021-10-13 | 2024-04-23 | Satio, Inc. | Mono dose dermal patch for pharmaceutical delivery |
| US12023156B2 (en) | 2021-10-13 | 2024-07-02 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US12053284B2 (en) | 2021-11-08 | 2024-08-06 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US12214346B2 (en) | 2021-10-13 | 2025-02-04 | Satio, Inc. | Dermal patch with a diagnostic test strip |
| US12048543B2 (en) | 2021-11-08 | 2024-07-30 | Satio, Inc. | Dermal patch for collecting a physiological sample with removable vial |
| US12178979B2 (en) | 2021-10-13 | 2024-12-31 | Satio, Inc. | Dermal patch for delivering a pharmaceutical |
| US11877848B2 (en) | 2021-11-08 | 2024-01-23 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US12029562B2 (en) | 2021-04-14 | 2024-07-09 | Satio, Inc. | Dermal patch system |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5795564A (en) * | 1991-04-05 | 1998-08-18 | Sepracor, Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
| DE19541689A1 (de) * | 1994-11-14 | 1996-05-15 | Byk Gulden Lomberg Chem Fab | Kombinationsarzneimittel |
| AU710382B2 (en) * | 1995-04-14 | 1999-09-16 | Glaxo Wellcome Inc. | Metered dose inhaler for albuterol |
| GB9612297D0 (en) * | 1996-06-11 | 1996-08-14 | Minnesota Mining & Mfg | Medicinal aerosol formulations |
| US6054488A (en) * | 1996-06-11 | 2000-04-25 | 3M Innovative Properties Company | Medicinal aerosol formulations of formoterol |
| US6129905A (en) * | 1997-04-21 | 2000-10-10 | Aeropharm Technology, Inc. | Aerosol formulations containing a sugar as a dispersant |
| US6120752A (en) * | 1997-05-21 | 2000-09-19 | 3M Innovative Properties Company | Medicinal aerosol products containing formulations of ciclesonide and related steroids |
| DE19753301A1 (de) * | 1997-12-01 | 1999-06-02 | Basf Ag | Verfahren zur Herstellung von Lactamen |
| US6264923B1 (en) * | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
| KR100600423B1 (ko) * | 1998-06-18 | 2006-07-13 | 베링거 인겔하임 파마슈티칼즈, 인코포레이티드 | 2개 이상의 활성 물질을 포함하는 연무질 약제학적 제형 |
| US6451285B2 (en) * | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
| CA2338680C (en) * | 1998-08-04 | 2008-10-14 | Jago Research Ag | Medicinal aerosol formulations |
| US6004537A (en) * | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
| AU5858501A (en) * | 2000-05-23 | 2001-12-03 | Glaxo Group Ltd | Aerosol container for formulations of salmeterol xinafoate |
-
2002
- 2002-04-05 GB GBGB0207899.6A patent/GB0207899D0/en not_active Ceased
-
2003
- 2003-04-01 JP JP2003583372A patent/JP5198716B2/ja not_active Expired - Fee Related
- 2003-04-01 AU AU2003262146A patent/AU2003262146A1/en not_active Abandoned
- 2003-04-01 AT AT03746589T patent/ATE401056T1/de not_active IP Right Cessation
- 2003-04-01 DE DE60322200T patent/DE60322200D1/de not_active Expired - Lifetime
- 2003-04-01 EP EP03746589A patent/EP1492500B1/en not_active Expired - Lifetime
- 2003-04-01 CA CA002481187A patent/CA2481187A1/en not_active Abandoned
- 2003-04-01 US US10/510,147 patent/US20050207984A1/en not_active Abandoned
- 2003-04-01 WO PCT/US2003/010285 patent/WO2003086349A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005529102A5 (enExample) | ||
| US7273603B2 (en) | HFC solution formulations containing an anticholinergic | |
| US12090139B2 (en) | Formulations comprising triptan compounds | |
| ES2325316T3 (es) | Composiciones farmaceuticas para el tratamiento del asma. | |
| JP2001526685A (ja) | 薬用エアゾール製品 | |
| JP2010505873A5 (ja) | 化合物、会合複合体、及び会合複合体を形成する方法 | |
| JP2004521134A5 (enExample) | ||
| ATE401056T1 (de) | Formoterol und ciclesonid aerosol-formulierungen | |
| JP2005522421A5 (enExample) | ||
| WO2003066026A1 (en) | Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier | |
| IL104068A (en) | Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant | |
| FR2798290A1 (fr) | Formulation pharmaceutique de propionate de fluticasone | |
| WO2016018892A1 (en) | Method of preparing a pharmaceutical composition | |
| JP2009541387A5 (enExample) | ||
| JP2002532428A (ja) | フルオロアルカンおよびブデソニドを含有する医薬用エアゾール製剤 | |
| WO2008053250A3 (en) | Formulations for delivery via pressurised metered dose inhalers comprising an essential oil as suspension stabiliser | |
| HUP0302036A2 (hu) | Glükokortikoidot tartalmazó készítmény bronchopulmonális betegségek kezelésére | |
| JP2003530352A (ja) | サルメテロール及びイプラトロピウムを含む医薬組成物 | |
| TW200913984A (en) | Acetamide stereoisomer | |
| JP2016517435A5 (ja) | メロペネム誘導体及びその製造法 | |
| JP2013518061A5 (enExample) | ||
| JP2005501082A5 (enExample) | ||
| JP6815109B2 (ja) | デュロキセチンまたは薬学的に許容されるその塩を有効成分とする医薬組成物 | |
| JP2024546201A (ja) | サルブタモールを含む医薬組成物 | |
| JP2002212063A5 (enExample) |